Cancer Biologists are scientists dedicated to understanding the fundamental mechanisms that drive cancer development, progression, and metastasis. Their research focuses on cellular and molecular processes, such as gene mutations, DNA repair failures, cell signaling pathways, and interactions within the tumor microenvironment. By studying how normal cells transform into cancerous ones, cancer biologists uncover the root causes of various cancer types and identify potential targets for new therapies. Their work often involves analyzing tumor samples, using model organisms, and applying advanced techniques like genomics, proteomics, and CRISPR-based gene editing to investigate cancer biology at the molecular level.
The discoveries made by cancer biologists are essential to the development of more effective diagnostics, treatments, and prevention strategies. Their findings often form the scientific foundation for clinical innovations such as targeted therapies, immunotherapies, and personalized medicine. By identifying specific genetic mutations or biomarkers, cancer biologists help guide treatment decisions and enable earlier, more accurate diagnoses. They also play a vital role in preclinical drug development, testing new compounds in laboratory models before they move into clinical trials. Through their relentless pursuit of knowledge, cancer biologists contribute significantly to reducing cancer-related mortality and improving patient outcomes. Their work, though often behind the scenes, drives many of the advances seen in modern oncology.
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : tRNA-derived fragment 3′tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer
Feng Yan, The Affiliated Cancer Hospital of Nanjing Medical University, China
Title : Integrating single-cell and spatial transcriptomics to uncover and elucidate GP73-mediated pro-angiogenic regulatory networks in hepatocellular carcinoma
Jiazhou Ye, Guangxi Medical University Cancer Hospital, China
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Analysis of the dynamic evolution and influencing factors of nutritional risk in breast cancer patients during treatment
Jingwen Yan, Sun Yat-sen University, China
Title : Integrative multi-omics reveals metabolic–stemness coupling and novel therapeutic targets in osteosarcoma chemoresistance
Jinyan Feng, Tianjin Medical University Cancer Institute and Hospital, China